The emergence and spread of antimicrobial resistance have been identified as a significant problem for human health that profoundly impacts clinical outcomes and healthcare-associated costs.
The emergence and spread of antimicrobial resistance have been identified as a significant problem for human health that profoundly impacts clinical outcomes and healthcare-associated costs. The overuse and misuse of antibiotics have resulted in antimicrobial resistance, as antibiotics are commonly prescribed without a definitive diagnosis. Antibiotic stewardship is the effort by healthcare providers to measure and improve how antibiotics are prescribed by clinicians and used by patients. It includes prescribing antibiotics only when needed (i.e., for bacterial infections, not viral ones), prescribing the appropriate antibiotics for the diagnosed infection, prescribing the correct dose and duration of antibiotic treatment, and combat antibiotic resistance. Hence, biomarkers have emerged as potentially useful diagnostic tools to help physicians triage, diagnose, stratify risk, and monitor the clinical course and respond to antibiotics. PCT (procalcitonin) is the most widely studied biomarker for antibiotic stewardship. It has been tested to aid the initiation or discontinuation of antibiotics, both in children and adults.
Request for sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00023261/
Top Leading companies like
- Thermo Fisher Scientific
- Qiagen
- Merck
- Abbott
- Bio-Rad Laboratories
- Roche
- HiMedia Laboratories
- Danaher Corporation
- Creative Diagnostic
- Agilent Technologies
The “Global Antibiotic Stewardship Biomarkers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibiotic stewardship biomarkers market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading antibiotic stewardship biomarkers market players and offers key trends and opportunities in the market.
Market Segmentation
Based on type, the global antibiotic stewardship biomarkers market is segmented into blood biomarkers and urine biomarkers.
On the basis of application, the market is bifurcated into diagnostics, drug discovery, personalized medicine and others.
Drivers
Rising diagnostic applications of biomarkers drive the antibiotic stewardship biomarkers market.
Increasing research and development activities propel the market growth.
Technological advancement in disease diagnosis and increasing lower respiratory tract infections fuel the market growth.
Antibiotic stewardship biomarkers act as cornerstones in the treatment of infection that boosts the market growth.
Restraints
Insufficient microbiological information.
Limited drug availability.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibiotic stewardship biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
Impact Of Covid-19 On Antibiotic Stewardship Biomarkers Market
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. During COVID-19, the antibiotic stewardship biomarkers market witnessed growth as biomarkers were used to predict secondary infections in ICU patients. CRP was usually increased in patients with COVID-19, and serum procalcitonin (PCT) helps in the identification of secondary infections in patients with COVID-19. It was found that a high proportion of COVID-19 patients received unnecessary antibiotic treatment. The increase in antibiotic administration can result in antibiotic resistance. Hence, it was suggested that a potential consequence of the COVID-19 pandemic might be an accelerated propagation of antimicrobial resistance. Therefore, clinicians, hospitals, microbiology labs, and public health organizations need to monitor the potential impact of increased antimicrobial consumption on the emergence of resistance in patients. The overall results from carefully designed studies can be utilized to prescribe rational antimicrobial treatment and stewardship strategies and develop diagnostic criteria for secondary bacterial infections in the future.
Antibiotic Stewardship Biomarkers Market Research Report Investigations Research Methodology review comprises of Secondary Research, Primary Research, Company Share Analysis, Model (including Demographic information, Macroeconomic pointers, and Industry markers for example Use, framework, area development, and offices, and so forth), Research Limitations and Revenue Based Modelling. Complete examination of Global Antibiotic Stewardship Biomarkers Market Based on current investigation and future examination, which depends on notable information additionally included in this Reports.
Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Antibiotic Stewardship Biomarkers market.
- Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
- The key findings and recommendations highlight crucial progressive industry trends in the Antibiotic Stewardship Biomarkers market, thereby allowing players to develop effective long term strategies in order to garner their market revenue.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Purchase a copy of the report @ https://www.theinsightpartners.com/buy/TIPRE00023261/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com